Does performing a Point-Of-Care HbA1c test increase the chances of undertaking an OGTT among individuals at risk of diabetes? A randomized controlled trial

被引:1
作者
Castano, Ramon A. [1 ]
Granados, Maria A. [2 ]
Trujillo, Natalia [2 ]
Bernal, Juan P. [2 ]
Trujillo, Juan F. [2 ]
Trasmondi, Patrizia [2 ]
Maestre, Angel F. [2 ]
Cardona, Juan S. [2 ]
Gonzalez, Rossmary [2 ]
Larrarte, Maria A. [2 ]
Hernandez, Derly C. [2 ]
Barengo, Noel C. [3 ,4 ]
Reynales, Humberto [2 ]
机构
[1] UEB Univ El Bosque, Fac Med, Bogota, Colombia
[2] CAIMED Ctr Atenc & Invest Med, Chia, Colombia
[3] Florida Int Univ, Herbert Wertheim Coll Med, HWCM Dept Med Educ, Miami, FL USA
[4] Univ Nacl Mar del Plata, UNMdP Escuela Super Med, Mar Del Plata, Argentina
关键词
Diabetes; Diabetes Mellitus; HbAIc; Glycosylated Hemoglobin Measurement; SCORE; GLUCOSE;
D O I
10.1016/j.pcd.2024.09.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Early detection of type 2 diabetes mellitus is key to reducing micro and macrovascular complications associated with this disease. However, a lab-based process for diagnosis entails the risk of loss-to-follow-up. The objective of this study was to demonstrate if performing a point-of-care test of HbA1c immediately after a screening questionnaire will increase the proportion of individuals showing up for a lab-based confirmatory test as Point-of-care (POC) provides immediate availability, which is expected to reduce loss-to-follow-up. Research design and methods: This trial was a two-arm, randomized controlled, open-label study. Participants were recruited using the FINDRISC Score in a primary care and community setting. All 902 eligible participants were randomized into the intervention (n=511) and control (n=391) group. The intervention group was given information on healthy lifestyles, and a Point-of-care POC-HbA1c test was performed during the same visit. The control group was only given information on healthy lifestyles. Participants in both groups received a written prescription to have an oral glucose tolerance test (OGTT) performed within the next 30 days. Follow-up phone calls were made at 30 and 90 days to check if participant had undergone the test. The total duration of the intervention was 8 months. The posterior data analysis was made by using the Kolmogorov-Smirnoff test for the quantitative variables, and the descriptive statistics were expressed as means and standard deviation, or median and interquartile range 25 %-75 %, as appropriate. Results: At 30 days, 28% of participants in the intervention group and 26.1 % in the control group undertook the OGTT (RD 1.90%; 95% CI -3.94; 7.73). At 90 days, 35.8% of participants in the intervention group and 37.1 % in the control group undertook the OGTT. There was no statistically significant difference (RD - 3.17%; 95% CI -7.04; 0.70) between both groups. Conclusions: The data suggest that performing a POC-HbA1c test after the FINDRISC did not increase the percentage of individuals showing up for the OGTT.
引用
收藏
页码:624 / 631
页数:8
相关论文
共 31 条
[1]   A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia) Baseline characteristics of the study participants [J].
Acosta, Tania ;
Barengo, Noel C. ;
Arrieta, Astrid ;
Ricaurte, Carlos ;
Tuomilehto, Jaakko O. .
MEDICINE, 2018, 97 (01)
[2]   Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country [J].
Alzubaidi, Hamzah ;
Hasan, Sanah ;
Saidawi, Ward ;
Mc Namara, Kevin ;
Chandir, Subhash ;
Krass, Ines .
DIABETIC MEDICINE, 2021, 38 (08)
[3]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[4]  
American Diabetes Association, 2024, 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024, DOI [10.2337/dc24-S002, DOI 10.2337/DC24-S002]
[5]  
Barengo NC, 2016, HERZ, V41, P175, DOI 10.1007/s00059-016-4417-5
[6]   A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation [J].
Barengo, Noel Christopher ;
Tamayo, Diana Carolina ;
Tono, Teresa ;
Tuomilehto, Jaakko .
PRIMARY CARE DIABETES, 2017, 11 (01) :86-93
[7]   Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions [J].
Barry, Eleanor ;
Roberts, Samantha ;
Oke, Jason ;
Vijayaraghavan, Shanti ;
Normansell, Rebecca ;
Greenhalgh, Trisha .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
[8]   Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension [J].
Butcher, Nancy J. ;
Monsour, Andrea ;
Mew, Emma J. ;
Chan, An-Wen ;
Moher, David ;
Mayo-Wilson, Evan ;
Terwee, Caroline B. ;
Chee-A-Tow, Alyssandra ;
Baba, Ami ;
Gavin, Frank ;
Grimshaw, Jeremy M. ;
Kelly, Lauren E. ;
Saeed, Leena ;
Thabane, Lehana ;
Askie, Lisa ;
Smith, Maureen ;
Farid-Kapadia, Mufiza ;
Williamson, Paula R. ;
Szatmari, Peter ;
Tugwell, Peter ;
Golub, Robert M. ;
Monga, Suneeta ;
Vohra, Sunita ;
Marlin, Susan ;
Ungar, Wendy J. ;
Offringa, Martin .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (22) :2252-2264
[9]   Implementing HbA1c monitoring in sub-Saharan Africa: Lessons learnt from a pilot project in Mozambique [J].
Ciccacci, Fausto ;
Ismael, Flavio ;
Parruque, Fernanda ;
Maquete, Dercio Julio ;
Loureiro, Sandra ;
Balamala, Moises ;
Morviducci, Leilo ;
Manto, Andrea ;
Lanti, Fabiana ;
Orlando, Stefano ;
Guidotti, Giovanni .
PUBLIC HEALTH IN PRACTICE, 2024, 7
[10]  
Fondo Colombiano de Enfermedades de Alto Costo, 2022, Situacion de la enfermedad renal cronica, la hipertension arterial y la diabetes mellitus en Colombia 2022